Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Morimoto

Showing results (671-680 of 728) with videos related to

Pageof 73
Sort By:
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders]K Torizuka, K Uemura, M Toru, et al.
Indoor Air|June 4, 2013
Phosphorus flame retardants in indoor dust and their relation to asthma and allergies of inhabitantsA Araki, I Saito, A Kanazawa, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 1)--report on clinical usefulness in diagnosis of various brain diseases]K Torizuka, K Uemura, M Toru, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 3)--Report on clinical usefulness in epilepsy]K Torizuka, K Uemura, M Toru, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 4)--Report on clinical usefulness in diagnosis of cerebrovascular diseases]K Torizuka, K Uemura, M Toru, et al.
Physical Review Letters|November 26, 2016
Signatures of Hyperfine, Spin-Orbit, and Decoherence Effects in a Pauli Spin BlockadeT Fujita, P Stano, G Allison, et al.
Mutagenesis|November 24, 1999
Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU)T Matsushima, M Hayashi, A Matsuoka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2001
The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependentD C Hooper, R B Kean, G S Scott, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Paraná, BrazilHelena K Morimoto, Adele Caterino-De-Araujo, Arilson A Morimoto, et al.
European Journal of Epidemiology|June 1, 1997
Effect of maternal lifestyle on cord blood IgE factorT Shirakawa, K Morimoto, S Sasaki, et al.
Pageof 73

Showing results (671-680 of 728) with videos related to

Sort By:
Pageof 73
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders]K Torizuka, K Uemura, M Toru, et al.
Indoor Air|June 4, 2013
Phosphorus flame retardants in indoor dust and their relation to asthma and allergies of inhabitantsA Araki, I Saito, A Kanazawa, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 1)--report on clinical usefulness in diagnosis of various brain diseases]K Torizuka, K Uemura, M Toru, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 3)--Report on clinical usefulness in epilepsy]K Torizuka, K Uemura, M Toru, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1996
[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 4)--Report on clinical usefulness in diagnosis of cerebrovascular diseases]K Torizuka, K Uemura, M Toru, et al.
Physical Review Letters|November 26, 2016
Signatures of Hyperfine, Spin-Orbit, and Decoherence Effects in a Pauli Spin BlockadeT Fujita, P Stano, G Allison, et al.
Mutagenesis|November 24, 1999
Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU)T Matsushima, M Hayashi, A Matsuoka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2001
The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependentD C Hooper, R B Kean, G S Scott, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Paraná, BrazilHelena K Morimoto, Adele Caterino-De-Araujo, Arilson A Morimoto, et al.
European Journal of Epidemiology|June 1, 1997
Effect of maternal lifestyle on cord blood IgE factorT Shirakawa, K Morimoto, S Sasaki, et al.
Pageof 73